PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 89 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2022. The put-call ratio across all filers is 1.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,346 | -25.5% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $9,859 | +14.2% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $8,630 | -27.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $11,814 | +68.8% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $7,000 | -12.5% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $8,000 | 0.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,000 | 0.0% | 2,793 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $8,000 | -60.0% | 2,793 | 0.0% | 0.00% | -80.0% |
| Q3 2021 | $20,000 | -23.1% | 2,793 | 0.0% | 0.01% | -16.7% |
| Q2 2021 | $26,000 | -3.7% | 2,793 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $27,000 | -6.9% | 2,793 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $29,000 | +3.6% | 2,793 | 0.0% | 0.01% | -12.5% |
| Q3 2020 | $28,000 | -3.4% | 2,793 | 0.0% | 0.01% | -11.1% |
| Q2 2020 | $29,000 | +20.8% | 2,793 | 0.0% | 0.01% | 0.0% |
| Q1 2020 | $24,000 | 0.0% | 2,793 | 0.0% | 0.01% | +12.5% |
| Q4 2019 | $24,000 | – | 2,793 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |